Objective To investigate which specific clinical factors influence patients choice of prolapse treatment. Methods This study includes a total of 510 cases with symptomatic pelvic organ prolapse (POP) of stage II or higher requiring prolapse treatment. Patients were divided into surgery and pessary groups according to their own choice and treatment preference. Primary outcome of interest was to define potential clinical parameters, which contribute to surgical treatment decision. Results A total of 252/510 (49%) women decided for prolapse surgery and 258/510 (51%) cases were treated conservatively with vaginal pessary. Hypertension, COPD as well as polypharmacy were parameters, which were statistically significantly more common in the pes...
textabstractIntroduction and hypothesis: To identify practice variation in management of patients wi...
Introduction and hypothesis: To identify practice variation in management of patients with a vaginal...
INTRODUCTION: With the publication of the updated US Food and Drug Administration (FDA) communicatio...
INTRODUCTION AND HYPOTHESIS: The objective of this study was to compare the functional outcomes afte...
INTRODUCTION AND HYPOTHESIS: The objective of this study was to compare the functional outcomes afte...
Objective: To compare the 24-month efficacy of pessary or surgery as the primary treatment for sympt...
To identify the factors associated with the prescription of vaginal pessaries (VPs) as a conservativ...
(1) Background: Pelvic organ prolapse (POP) can be managed using a vaginal pessary. However, the dec...
Background: Given the prevalence of women seeking surgical treatment for pelvic organ prolapse (POP)...
Objective: The aim of this study was to assess the prevalence and the related factors of pelvic org...
The true incidence of pelvic organ prolapse (POP) is difficult to determine, however, it is a common...
Background: Pelvic organ. prolapse may occur in up to 50% of parous women. A variety of urinary, bow...
Background: Pelvic organ prolapse (POP) is a relatively common condition. In Sweden, the overall est...
Pelvic organ prolapse is a common condition. There is inconsistency between predictors of unsuccessf...
Introduction and Hypothesis: There is variable evidence on predictors of successful fitting of vagin...
textabstractIntroduction and hypothesis: To identify practice variation in management of patients wi...
Introduction and hypothesis: To identify practice variation in management of patients with a vaginal...
INTRODUCTION: With the publication of the updated US Food and Drug Administration (FDA) communicatio...
INTRODUCTION AND HYPOTHESIS: The objective of this study was to compare the functional outcomes afte...
INTRODUCTION AND HYPOTHESIS: The objective of this study was to compare the functional outcomes afte...
Objective: To compare the 24-month efficacy of pessary or surgery as the primary treatment for sympt...
To identify the factors associated with the prescription of vaginal pessaries (VPs) as a conservativ...
(1) Background: Pelvic organ prolapse (POP) can be managed using a vaginal pessary. However, the dec...
Background: Given the prevalence of women seeking surgical treatment for pelvic organ prolapse (POP)...
Objective: The aim of this study was to assess the prevalence and the related factors of pelvic org...
The true incidence of pelvic organ prolapse (POP) is difficult to determine, however, it is a common...
Background: Pelvic organ. prolapse may occur in up to 50% of parous women. A variety of urinary, bow...
Background: Pelvic organ prolapse (POP) is a relatively common condition. In Sweden, the overall est...
Pelvic organ prolapse is a common condition. There is inconsistency between predictors of unsuccessf...
Introduction and Hypothesis: There is variable evidence on predictors of successful fitting of vagin...
textabstractIntroduction and hypothesis: To identify practice variation in management of patients wi...
Introduction and hypothesis: To identify practice variation in management of patients with a vaginal...
INTRODUCTION: With the publication of the updated US Food and Drug Administration (FDA) communicatio...